Search

everythinglearnresearchcommunity

for

Search:↓

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The committee decided not to approve the drug due to low effectiveness and high risks.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Hyaluronic acid is useful in cancer treatment, wound healing, and managing diseases due to its tissue compatibility and drug delivery abilities.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Certain drugs that block specific enzymes can help treat prostate diseases.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Sun exposure and genetics increase skin cancer risk from precancerous lesions.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Nanotechnology shows promise for better drug delivery and cancer treatment.

A new method accurately measures a drug in skin for cancer therapy research.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.